Numbers Are Down as Continued Economic Uncertainty Hinders Direct Sellers

CEOs report a ‘turbulent,’ ‘volatile,’ and ‘challenging’ Q3

By:  Dave Rauf

“As we look ahead, we anticipate continued COVID-related inflationary and economic challenges in many of our markets.” —Kevin Guest, CEO, USANA

USANA

USANA Health Sciences reported a turbulent third quarter, as inflationary pressure coupled with COVID-19 disruptions in Asia led to double-digit sales and profit declines. 

The weaker-than-expected performance during the quarter prompted USANA to lower its full-year guidance for 2022, as the company reported lower sales than the same period a year ago in all of its markets.